Award
Minnesota FOIA #N008978103
NEOLEV3: A Phase IIb Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures of Mild to Moderate...
Recipient
AUCKLAND HOSPITALS RESEARCH
Award Amount
$61,130.00
Ceiling
$61,130.00
Awarded
March 28, 2023
Identifier
N008978103
Description
NEOLEV3: A Phase IIb Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures of Mild to Moderate Severity IND-109622